You are Unregistered, please register to gain Full access.    

New cases in Pous 2064, HIV = 175, AIDS = 26, Death = 2. HIV rate is very high in Housewives than sex workers in Nepal ! ! ! HIV status in Nepal till 2005: Total Adult=70000, Adult Prevalence (15-49)=0.55%, Number of Women (15-49) LWHA=15,310 (22%), HIV Prevalence rate in IDUs=32.7%, HIV prevalence rate in sex worker=3.8%, HIV prevalence rate in client of SW=2.1%. The latest U.N. report shows that 65 million people have been infected with HIV since it was first identified 25 years ago. Twenty five million people have died of AIDS.

Welcome to the xenoMED, an online Medical Community where Academically sound, Professionally conscious and Socially responsible Medical Students, Doctors & Health Professionals interact with each other globally.

Medicine is the only profession that incessantly tries to destroy its own existence. Howsoever you may be associated with basic and/or clinical medicine - student or professor, physician or surgeon, undergraduate or postgraduate - this is your place to share your knowledge, and learn more. Just get the message across!

You are currently viewing our communiy as a guest which gives you limited access to view most discussions and access our other features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, Join Our Medical Cummunity Today!

If you have any problems with the registration process or your account login, please contact us.
Go Back   xenoMED > News Room > Nepal Health News
Nepal Health News Exclusive Coverage on Nepalese Health News

Comment
 
LinkBack Article Tools Display Modes
<!-- google_ad_section_start -->Pharmaceuticals ban: Doctor ignores explanation notice<!-- google_ad_section_end -->
Pharmaceuticals ban: Doctor ignores explanation notice
Published by bijaychy
14-06-2008
Pharmaceuticals ban: Doctor ignores explanation notice

Rabin Giri Dharan, June 13:

A three-day notice by the authority of the BP Koirala Institute of Health Sciences to the ENT department head Dr Sangeeta Bhandari to explain why she prevented certain pharmaceutical companies from entering the department, expired yesterday.
Dr Bhandari has not complied with the deadline to explain why she prevented pharmaceuticals
including Aristo, Quest, Merk, Asian, Norvitis and Time from entering the department.
Hospital Superintendent Dr BP Das said, “We will decide on future action after she furnishes her reply.”
On May 16, The Himalayan Times had carried a report on Ear Nose and Throat (ENT) department head Dr Bhandari arbitrarily blacklisting certain pharmaceuticals and causing problems for patients.
Sangeeta Shah, chief of the Drug Administration Department regional office Biratnagar, said the pharmaceutical companies reportedly blacklisted by Dr Bhandari are reputed ones.
Shah said, “No doctor has the authority to blacklist pharmaceuticals or their products on their own. Procedure demands that a complaint must be filed in this regard to the DDA.”
After the May 16 THT story, Dr Bhandari has put more strongly-worded notices on the door to her chamber and in every room and on walls of the department denying them access to the department.
Defending her decision, Dr Bhandari told this daily, “These companies don’t cooperate in educational programmes initiated by the department and obstruct our work. I have blacklisted the pharmaceuticals for their nuisance value.”
source-http://www.thehimalayantimes.com/fullstory.asp?filename=aNPata0sgqzpca6Ua3sa.axamal &folder=aNPataiaoanaaal&Name=National&sImageFileNa me=&dtSiteDate=20080614
Article Tools

Featured Articles
The Following User Says Thank You to bijaychy For This Useful Post:
mralone (22-06-2008)
Comment


Article Tools
Display Modes

Posting Rules
You may not post new articles
You may not post comments
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On


Similar Threads
Article Article Starter Category Comments Last Post
Wyeth Pharmaceuticals And Solvay Pharmaceuticals, Inc. Announce Receipt Of An FDA Act Angel Medical News Today 0 11-08-2007 01:03 AM
Sucampo Pharmaceuticals Submits Supplemental New Drug Application For Lubiprostone To Angel Medical News Today 0 13-07-2007 12:32 AM
Koronis Pharmaceuticals Receives Notice Of Allowance On Patent For Novel Therapeutic Angel Medical News Today 0 20-04-2007 12:15 AM
Bradley Pharmaceuticals Announces FDA Approval Of Elestrin(TM) (estradiol Gel 0.06%) Angel Medical News Today 0 20-12-2006 12:12 AM
Napo Pharmaceuticals Announces The Successful Production Of Crofelemer Active Pharmac Angel Medical News Today 0 18-11-2006 12:12 AM



Powered by vBulletin® Version 3.6.8
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO 3.1.0
vBulletin Skin developed by: vBStyles.com
Copyright © 2005-2007 xenoMED, Kathmandu, Nepal
Article powered by GARS 2.1.8m ©2005-2006Ad Management by RedTyger
Hosted and Maintained by: